Form 8-K - Current report:
SEC Accession No. 0001104659-25-044349
Filing Date
2025-05-05
Accepted
2025-05-05 07:06:05
Documents
14
Period of Report
2025-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2513949d1_8k.htm   iXBRL 8-K 24716
2 EXHIBIT 99.1 tm2513949d1_ex99-1.htm EX-99.1 85830
  Complete submission text file 0001104659-25-044349.txt   296187

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ocul-20250505.xsd EX-101.SCH 3005
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocul-20250505_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocul-20250505_pre.xml EX-101.PRE 22352
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2513949d1_8k_htm.xml XML 3564
Mailing Address 15 CROSBY DRIVE BEDFORD MA 01730
Business Address 15 CROSBY DRIVE BEDFORD MA 01730 781-357-4000
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36554 | Film No.: 25910856
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)